HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two novel homozygous SACS mutations in unrelated patients including the first reported case of paternal UPD as an etiologic cause of ARSACS.

Abstract
Autosomal recessive spastic ataxia of Charlevoix-Saguenay, more commonly known as ARSACS, is an early-onset cerebellar ataxia with spasticity, amyotrophy, nystagmus, dysarthria, and peripheral neuropathy. SACS is the only gene known to be associated with the ARSACS phenotype. To date, 55 mutations have been reported; of these, only five in Italian patients. We found two novel homozygous nonsense mutations in the giant exon of SACS gene in two unrelated patients with classical ARSACS phenotype. Characterization of the homozygous nature of the mutations through genotyping of the parents, quantitative DNA analysis and indirect STS studies permitted us to confirm in one of the cases that uniparental isodisomy of the paternal chromosome 13 carrying the mutated SACS gene played an etiologic role in the disease.
AuthorsLaura Anesi, Paola de Gemmis, Massimo Pandolfo, Uros Hladnik
JournalJournal of molecular neuroscience : MN (J Mol Neurosci) Vol. 43 Issue 3 Pg. 346-9 (Mar 2011) ISSN: 1559-1166 [Electronic] United States
PMID20852969 (Publication Type: Journal Article)
Chemical References
  • Heat-Shock Proteins
  • SACS protein, human
Topics
  • Adult
  • Chromosomes, Human, Pair 13
  • DNA Mutational Analysis
  • Female
  • Genotype
  • Haplotypes
  • Heat-Shock Proteins (genetics)
  • Homozygote
  • Humans
  • Male
  • Muscle Spasticity (etiology, genetics, physiopathology)
  • Mutation
  • Pedigree
  • Phenotype
  • Spinocerebellar Ataxias (congenital, etiology, genetics, physiopathology)
  • Uniparental Disomy (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: